From The Foundry, an Incubator Focused on Ophthalmology

The Foundry has created a new incubator to focus on ophthalmology, Forsight Labs, in partnership with Eugene de Juan, MD, a leading ophthalmologist and serial entrepreneur, who was one of the founders of Second Sight, and InnoRx.

Two years ago, executives from venture capital firm Morgenthaler Ventures and medical device incubator The Foundry flew across the country to talk to officials from the Naval Research Laboratories (NRL) in Washington, DC. "The NRL has a silicon foundry that was doing interesting work in producing a silicon matrix that could be implanted in the retina to restore vision for those who had lost their sight," recalls Robin Bellas, a partner at Morgenthaler.

The idea was to launch a company from The Foundry, to be called Percept, but Morgenthaler and The Foundry decided...

More from Business Strategy

More from In Vivo

Podcast: Acuitas CSO On CRISPR Delivery Breakthrough And Next-Gen Lipid Nanoparticle Technology

 
• By 

In Vivo sits down with Ying Tam, CSO at Acuitas Therapeutics, to discuss the company's role in delivering the first personalized CRISPR treatment to an infant and the clinical implications of new lipid nanoparticle technologies.

BioBytes: AI-Related Deals In Q2 ‘25

 
• By 

When it came to AI-related deals, the second quarter of 2025 was characterized by mostly modest financings.

Titans Of Pharma: Lilly’s Ricks Tops Big Pharma Pay Chart

 

The big pharma CEO with the highest-valued compensation in 2024 was David Ricks of Eli Lilly, while Pfizer and J&J executives slipped into third and fourth place behind AbbVie's now retired chief Richard Gonzalez. European firms brought up the rear.